A collaborative research and development partnership between researchers at the University of Georgia and Sanofi Pasteur, the largest influenza vaccine manufacturer in the world, has resulted in the identification of a vaccine ...
Nov 2, 2017
0
2
Hulking gray boxes are rolling off the production line at a factory in the southern town of Tuttlingen, ready to be shipped to the front in the next phase of Germany's battle against the coronavirus as it became the latest ...
Nov 27, 2020
0
3
For many immunocompromised people, the COVID-19 pandemic has been a living nightmare—and the omicron variant may make life even more unsettling.
Jan 7, 2022
0
27
(HealthDay)—The recombinant influenza vaccine (RIV4) is well tolerated in children aged 6 to 17 years, and it provides immunogenicity comparable to that of the inactivated vaccine, according to a study published online ...
Apr 2, 2018
0
2
In 2020, when COVID-19 infection rates were at their peak, the world looked to science and global cooperation to find a vaccine that would prevent further illness and deaths.
Jan 13, 2022
0
6
The scientist who won the race to deliver the first widely used coronavirus vaccine says people can rest assured the shots are safe, and the technology behind it will soon be used to fight another global scourge—cancer.
Mar 19, 2021
0
6
The World Health Organization blasted the senseless "greed" of rich countries considering COVID-19 booster vaccinations while the most vulnerable in other nations were left exposed to the virus.
Jul 12, 2021
3
1
Swiss pharmaceuticals giant Novartis said Friday it had signed an initial agreement to help produce the Pfizer-BioNTech vaccine against COVID-19, as countries scramble to boost supplies.
Jan 29, 2021
0
24
Young children who received the 4CMenB vaccine as infants to protect against serogroup B meningococcal disease had waning immunity by age 5, even after receiving a booster at age 3 ½, according to new research in CMAJ (Canadian ...
Mar 23, 2015
0
5
AstraZeneca plans to accelerate production of its COVID vaccine in the second quarter to support EU needs, the British pharmaceutical giant said Wednesday, announcing a deal with Germany's IDT Biologika.
Feb 10, 2021
0
0
